Grams Morgan E, Matsushita Kunihiro, Sang Yingying, Estrella Michelle M, Foster Meredith C, Tin Adrienne, Kao W H Linda, Coresh Josef
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; andDepartments of Epidemiology and
Departments of Epidemiology and.
J Am Soc Nephrol. 2014 Aug;25(8):1834-41. doi: 10.1681/ASN.2013080867. Epub 2014 Apr 10.
African Americans face higher risk of AKI than Caucasians. The extent to which this increased risk is because of differences in clinical, socioeconomic, or genetic risk factors is unknown. We evaluated 10,588 African-American and Caucasian participants in the Atherosclerosis Risk in Communities study, a community-based prospective cohort of middle-aged individuals. Participants were followed from baseline study visit (1996-1999) to first hospitalization for AKI (defined by billing code), ESRD, death, or December 31, 2010. African-American participants were slightly younger (61.7 versus 63.1 years, P<0.001), were more often women (64.5% versus 53.2%, P<0.001), and had higher baseline eGFR compared with Caucasians. Annual family income, education level, and prevalence of health insurance were lower among African Americans than Caucasians. The unadjusted incidence of hospitalized AKI was 7.4 cases per 1000 person-years among African Americans and 5.8 cases per 1000 person-years among Caucasians (P=0.002). The elevated risk of AKI among African Americans persisted after adjustment for demographics, cardiovascular risk factors, kidney markers, and time-varying number of hospitalizations (adjusted hazard ratio, 1.20; 95% confidence interval [95% CI], 1.01 to 1.43; P=0.04); however, accounting for differences in income and/or insurance by race attenuated the association (P>0.05). High-risk APOL1 variants did not associate with AKI among African Americans (demographic-adjusted hazard ratio, 1.07; 95% CI, 0.69 to 1.65; P=0.77). In summary, the higher risk of AKI among African Americans may be related to disparities in socioeconomic status.
非裔美国人患急性肾损伤(AKI)的风险高于白种人。这种风险增加在多大程度上归因于临床、社会经济或遗传风险因素的差异尚不清楚。我们在社区动脉粥样硬化风险研究中评估了10588名非裔美国人和白种人参与者,该研究是一项基于社区的中年个体前瞻性队列研究。参与者从基线研究访视(1996 - 1999年)开始随访,直至首次因AKI住院(根据计费代码定义)、终末期肾病(ESRD)、死亡或到2010年12月31日。非裔美国参与者年龄稍小(61.7岁对63.1岁,P<0.001),女性比例更高(64.5%对53.2%,P<0.001),与白种人相比基线估算肾小球滤过率(eGFR)更高。非裔美国人的家庭年收入、教育水平和医疗保险普及率低于白种人。未调整的住院AKI发病率在非裔美国人中为每1000人年7.4例,在白种人中为每1000人年5.8例(P = 0.002)。在对人口统计学、心血管风险因素、肾脏标志物和随时间变化的住院次数进行调整后,非裔美国人中AKI风险升高仍然存在(调整后的风险比,1.20;95%置信区间[95%CI],1.01至1.43;P = 0.04);然而,考虑种族间收入和/或保险的差异会减弱这种关联(P>0.05)。高风险的载脂蛋白L1(APOL1)变异与非裔美国人的AKI无关(人口统计学调整后的风险比,1.07;95%CI,0.69至1.65;P = 0.77)。总之,非裔美国人中较高的AKI风险可能与社会经济地位差异有关。